Publication | Closed Access

A post-marketing evaluation of posaconazole plasma concentrations in neutropenic patients with haematological malignancy receiving posaconazole prophylaxis

Hematological MalignancyMedicinePosaconazole ProphylaxisHematologyPosaconazole Plasma ConcentrationsClinical MycologyPharmacotherapyPost-marketing EvaluationPharmacology